53067-04-2

Basic information

• Product Name: Cyclohexane, (2-chloroethoxy)-
• CAS NO: 53067-04-2
• Molecular Formula: C8H15ClO
• Molecular Weight: 162.66
• Mol File: 53067-04-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Cyclohexane, (2-chloroethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexane, (2-chloroethoxy)-(53067-04-2)
• EPA Substance Registry System: Cyclohexane, (2-chloroethoxy)-(53067-04-2)

Safety Data

• Hazardous Substances Data: 53067-04-2(Hazardous Substances Data)

Upstream product

• 107-07-3 2-chloro-ethanol 
• 110-83-8 cyclohexene 
• 108-93-0 cyclohexanol 
• 71995-54-5 2-(cyclohexyloxy)acetic acid 
• 22096-22-6 sodium cyclohexanolate 
• 1817-88-5 2-Cyclohexyloxyethanol 

Downstream Products

• 102945-46-0 1-(2-cyclohexyloxy-ethyl)-4-phenyl-piperidine-4-carboxylic acid ethyl ester 
• 98552-43-3 2-(cyclohexyloxy)acetamide 

Relevant articles and documents

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The invention relates to the field of medicine, discloses new nitrogen heterocyclic derivatives, preparation method thereof and as medicament in particular as the treatment and prevention of treating tissue fibrosis of the medicament. The invention also discloses a pharmaceutically acceptable compound of the present invention comprise a pharmaceutical composition and methods for using the composition for the treatment of the human or animal tissue fibrosis of diseases, in particular for treating the human or animal renal interstitial fibrosis, glomerular sclerosis, hepatic fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, skin fibrosis, after the operation of adhering, benign prostate hypertrophy, bone-myocardial, scleroderma, multiple sclerosis, pancreas fibrosis, liver cirrhosis, myosarcoma, neurofibromatosis, interstitial pulmonary fibrosis, diabetic nephropathy, Alzheimer's disease or vascular fibrosis disease in use. (by machine translation)